Fauconnet, Pascal, Ho, Vincent, Pastor, Catherine, and Schiffer, Eduardo (2011) Hepatopulmonary syndrome. In: Cardiovascular Diseases and Liver Transplantation. Cardiology Research and Clinical Developments . UNSPECIFIED, Nova Science Publishers, pp. 179-192.
|Image (JPEG) (Published Version)|
|PDF (Published Version) - Repository staff only - Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader|
View at Publisher Website: https://www.novapublishers.com/catalog/p...
Hepatopulmonary syndrome (HPS) is a pulmonary complication observed in patients with chronic liver disease and/or portal hypertension. HPS is attributable to an intrapulmonary vascular dilatation that induces severe hypoxemia. Considering the favorable long-term survival of HPS patients as well as the reversal of the syndrome with a functional liver graft, HPS is now an indication for liver transplantation (LT). Both patients with mild cirrhosis who present with shortness of breath and all patients with end stage liver disease who are candidates for liver transplantation should undergo screening for HPS. Blood gas analysis and contrast-enhanced echocardiography are two main screening tools, together with lung function tests that can also detect additional pulmonary diseases that can contribute to impaired oxygenation. If the partial pressure of oxygen in arterial blood (PaO2) is > 80 mmHg, HPS can be excluded and no other investigation is needed. However, when PaO2 is ≤ 80 mmHg, contrast-enhanced echocardiography should be performed to obtain evidence of or to exclude pulmonary vascular dilatation.
|Item Type:||Book Chapter (Research - B1)|
|FoR Codes:||11 MEDICAL AND HEALTH SCIENCES > 1103 Clinical Sciences > 110306 Endocrinology @ 100%|
|SEO Codes:||92 HEALTH > 9201 Clinical Health (Organs, Diseases and Abnormal Conditions) > 920106 Endocrine Organs and Diseases (excl. Diabetes) @ 100%|
|Deposited On:||19 Apr 2012 15:03|
|Last Modified:||19 Apr 2012 18:01|
Last 12 Months: 7
Repository Staff Only: item control page